Trial
NCT02365415
Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Boston Children's Hospital
Collaborators
—
Condition
Peripheral Pulmonary Stenosis
Intervention
Sirolimus
Why stopped
Unable to enroll appropriate patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-05